Gemina Laboratories Ltd. (CSE:GLAB)
0.2200
+0.0400 (22.22%)
Dec 5, 2025, 3:58 PM EST
Gemina Laboratories Balance Sheet
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 |
| Cash & Equivalents | 0.01 | 0 | 0 | 0.08 | 1.16 | 0.88 |
| Cash & Short-Term Investments | 0.01 | 0 | 0 | 0.08 | 1.16 | 0.88 |
| Cash Growth | 799.34% | -28.99% | -98.81% | -92.81% | 31.12% | - |
| Accounts Receivable | - | - | - | - | 0.01 | 0.02 |
| Other Receivables | 0.04 | 0.03 | 0.04 | 0.39 | 0.18 | 0 |
| Receivables | 0.04 | 0.03 | 0.04 | 0.39 | 0.19 | 0.02 |
| Prepaid Expenses | 0.07 | 0.07 | 0.05 | 0.09 | 0.03 | 0.01 |
| Restricted Cash | - | - | - | - | - | 1.54 |
| Total Current Assets | 0.12 | 0.11 | 0.09 | 0.56 | 1.38 | 2.45 |
| Property, Plant & Equipment | 0.04 | 0.31 | 0.37 | 0.32 | 0.04 | 0.05 |
| Long-Term Investments | 0.99 | 1.02 | 0.99 | 0.99 | - | - |
| Long-Term Accounts Receivable | - | - | - | - | - | 0.01 |
| Other Long-Term Assets | 0.02 | - | - | - | - | 0.02 |
| Total Assets | 1.19 | 1.44 | 1.46 | 1.87 | 1.42 | 2.53 |
| Accounts Payable | 2.92 | 2.86 | 1.67 | 0.93 | 0.33 | 0.08 |
| Accrued Expenses | 2.42 | 1.74 | 0.89 | 0.78 | 0.1 | 0.04 |
| Short-Term Debt | 0.24 | 1 | 0.2 | - | - | - |
| Current Portion of Leases | - | 0.1 | 0.08 | 0.04 | 0.04 | 0.06 |
| Other Current Liabilities | - | - | - | - | - | 2.15 |
| Total Current Liabilities | 5.58 | 5.7 | 2.84 | 1.75 | 0.47 | 2.33 |
| Long-Term Leases | - | 0.18 | 0.21 | 0.2 | 0.01 | 0.04 |
| Total Liabilities | 5.58 | 5.87 | 3.04 | 1.95 | 0.48 | 2.37 |
| Common Stock | 12.77 | 11.99 | 11.24 | 8.15 | 5.62 | 0.99 |
| Retained Earnings | -21.6 | -20.84 | -16.76 | -11.55 | -5.57 | -0.83 |
| Comprehensive Income & Other | 4.43 | 4.42 | 3.94 | 3.33 | 0.89 | - |
| Shareholders' Equity | -4.39 | -4.44 | -1.59 | -0.07 | 0.94 | 0.16 |
| Total Liabilities & Equity | 1.19 | 1.44 | 1.46 | 1.87 | 1.42 | 2.53 |
| Total Debt | 0.24 | 1.27 | 0.49 | 0.24 | 0.05 | 0.1 |
| Net Cash (Debt) | -0.23 | -1.27 | -0.48 | -0.16 | 1.11 | 0.78 |
| Net Cash Growth | - | - | - | - | 41.65% | - |
| Net Cash Per Share | -0.00 | -0.02 | -0.01 | -0.00 | 0.02 | 0.02 |
| Filing Date Shares Outstanding | 76.57 | 76.57 | 73.33 | 73.33 | 55.6 | 38.47 |
| Total Common Shares Outstanding | 76.57 | 74.97 | 73.33 | 65.85 | 55.6 | 38.47 |
| Working Capital | -5.46 | -5.59 | -2.74 | -1.19 | 0.91 | 0.12 |
| Book Value Per Share | -0.06 | -0.06 | -0.02 | -0.00 | 0.02 | 0.00 |
| Tangible Book Value | -4.39 | -4.44 | -1.59 | -0.07 | 0.94 | 0.16 |
| Tangible Book Value Per Share | -0.06 | -0.06 | -0.02 | -0.00 | 0.02 | 0.00 |
| Machinery | 0.07 | 0.07 | 0.08 | 0.06 | 0.01 | - |
| Leasehold Improvements | - | - | 0.05 | 0.03 | 0.02 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.